| Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 ... - Sacramento Bee |
|
|
Sacramento Bee Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, |